keyword
https://read.qxmd.com/read/38597874/prediction-of-acute-hepatotoxicity-with-human-pluripotent-stem-cell-derived-hepatic-organoids
#1
JOURNAL ARTICLE
Hyemin Kim, Sang Kyum Kim, Michael Oelgeschläger, Han-Jin Park
Recent development of hepatic organoids (HOs) derived from human pluripotent stem cells (hPSCs) provides an alternative in vitro model that can mimic the human liver detoxification pathway for drug safety assessment. By recapitulating the high level of maturity and drug-metabolizing capacity of the liver in a three-dimensional organoid culture, HOs may allow researchers to assess drug toxicity and metabolism more accurately than animal models or hepatocellular carcinoma cells. Although this promising potential has contributed to the development of various protocols, only a few protocols are available to generate functional HOs with guaranteed CYP450 enzymatic activity, the key feature driving toxic responses during drug metabolism...
April 2024: Current protocols
https://read.qxmd.com/read/38586400/genetic-polymorphisms-of-cyp2c19-in-ecuadorian-population-an-interethnic-approach
#2
JOURNAL ARTICLE
Alba Alonso Llorente, Josefa Salgado Garrido, Óscar Teijido Hermida, Fabricio González Andrade, Alberto Valiente Martín, Ana Julia Fanlo Villacampa, Jorge Vicente Romero
INTRODUCTION: CYP2C19 is a highly polymorphic gene responsible for metabolizing commonly used drugs. CYP2C19*2,*3 (loss of activity alleles) and *17 (increased activity allele) are the principal alleles included in clinical guidelines, however their prevalence varies among different ethnicities. Ecuadorian population is formed by Mestizos, Afrodescendants and Native Americans and frequency of CYP2C19 alleles could be different among them. The objective of this study was to establish the frequency of these variants in the different populations of Ecuador and to compare them with other populations...
April 15, 2024: Heliyon
https://read.qxmd.com/read/38452616/air-liquid-interface-culture-and-modified-culture-medium-promote-the-differentiation-of-human-induced-pluripotent-stem-cells-into-intestinal-epithelial-cells
#3
JOURNAL ARTICLE
Kotaro Shirai, Shimeng Qiu, Hanako Minowa, Tadahiro Hashita, Takahiro Iwao, Tamihide Matsunaga
An in vitro system that evaluates pharmacokinetics in the small intestine is crucial for the development of oral drugs. We produced human induced pluripotent stem cell-derived small intestinal epithelial cells (hiSIECs) with high drug metabolizing enzyme and drug transporter activities. However, the gene expression of our hiSIECs partially differed from that of the human small intestine, with low drug metabolizing enzyme activities. Therefore, we used air-liquid interface (ALI) culture and 5-aza-2'-deoxycytidine (5AZA)-free medium to generate hiSIECs (novel hiSIECs)...
December 31, 2023: Drug Metabolism and Pharmacokinetics
https://read.qxmd.com/read/38450679/the-cytotoxic-and-antiproliferative-properties-of-ruthenium-nitrosyl-complexes-and-their-modulation-effect-on-cytochrome-p450-in-the-hepg2-cell-line
#4
JOURNAL ARTICLE
L S Klyushova, V A Vavilin, A Yu Grishanova
Ruthenium nitrosyl complexes are actively investigated as antitumor agents. Evaluation of potential interactions between cytochromes P450 (CYPs) with new compounds is carried out regularly during early drug development. In this study we have investigated the cytotoxic and antiproliferative activities of ruthenium nitrosyl complexes with methyl/ethyl esters of nicotinic and isonicotinic acids and γ-picoline against 2D and 3D cultures of human hepatocellular carcinoma HepG2 and non-cancer human lung fibroblasts MRC-5, assessed their photoinduced activity at λrad = 445 nm, and also evaluated their modulating effect on CYP3A4, CYP2C9, and CYP2C19...
February 2024: Biomedit︠s︡inskai︠a︡ Khimii︠a︡
https://read.qxmd.com/read/38393578/time-course-of-the-interaction-between-oral-short-term-ritonavir-therapy-with-three-factor-xa-inhibitors-and-the-activity-of-cyp2d6-cyp2c19-and-cyp3a4-in-healthy-volunteers
#5
JOURNAL ARTICLE
Brit S Rohr, Evelyn Krohmer, Kathrin I Foerster, Jürgen Burhenne, Martin Schulz, Antje Blank, Gerd Mikus, Walter E Haefeli
BACKGROUND: We investigated the effect of a 5-day low-dose ritonavir therapy, as it is used in the treatment of COVID-19 with nirmatrelvir/ritonavir, on the pharmacokinetics of three factor Xa inhibitors (FXaI). Concurrently, the time course of the activities of the cytochromes P450 (CYP) 3A4, 2C19, and 2D6 was assessed. METHODS: In an open-label, fixed sequence clinical trial, the effect and duration of a 5-day oral ritonavir (100 mg twice daily) treatment on the pharmacokinetics of three oral microdosed FXaI (rivaroxaban 25 µg, apixaban 25 µg, and edoxaban 50 µg) and microdosed probe drugs (midazolam 25 µg, yohimbine 50 µg, and omeprazole 100 µg) was evaluated in eight healthy volunteers...
February 23, 2024: Clinical Pharmacokinetics
https://read.qxmd.com/read/38346785/differential-effect-of-ticagrelor-versus-clopidogrel-by-homocysteine-levels-on-risk-of-recurrent-stroke-a-post-hoc-analysis-of-the-chance-2-trial
#6
RANDOMIZED CONTROLLED TRIAL
Anxin Wang, Xue Tian, Xuewei Xie, Hao Li, Philip M Bath, Jing Jing, Jinxi Lin, Yilong Wang, Xingquan Zhao, Zixiao Li, Liping Liu, Yongjun Wang, Xia Meng
BACKGROUND: Elevated homocysteine levels are associated with increased blood coagulation and platelet activity and may modulate the response to antiplatelet therapies. We aimed to investigate the effects of homocysteine levels on the efficacy and safety of ticagrelor-acetylsalicylic acid (ASA) versus clopidogrel-ASA among patients with minor stroke or transient ischemic attack who carried CYP2C19 loss-of-function alleles. METHODS: We conducted a post hoc analysis of the CHANCE-2 (The Clopidogrel in High-risk Patients with Acute Nondisabling Cerebrovascular Events-II) trial...
February 11, 2024: Canadian Medical Association Journal: CMAJ
https://read.qxmd.com/read/38286794/a-novel-allglo-probe-quantitative-pcr-method-for-detecting-single-nucleotide-polymorphism-in-cyp2c19-to-evaluate-the-antiplatelet-activity-of-clopidogrel
#7
JOURNAL ARTICLE
Hongwei Li, Yizhen Fang, Yongquan Chen, Yuning Lin, Zanxi Fang, Zhiyuan Lin, Huabin Xie, Zhongying Zhang
CYP2C19 gene has multiple single nucleotide polymorphism (SNP), which is the major determinant for clopidogrel treatment responses. Therefore, CYP2C19 SNP detection is essential for predicting clopidogrel efficacy. Currently, there is still no quick and effective method for routine detection of common CYP2C19 SNPs in clinical laboratories, which is critically needed prior to clopidogrel treatment. AllGlo™ based quantitative PCR was used to develop a novel genotyping method for CYP2C19 SNP detection, termed CyPAllGlo...
January 29, 2024: Scientific Reports
https://read.qxmd.com/read/38182943/comparative-metabolism-of-aschantin-in-human-and-animal-hepatocytes
#8
JOURNAL ARTICLE
Min Seo Lee, Hyun Joo Shim, Yong-Yeon Cho, Joo Young Lee, Han Chang Kang, Im-Sook Song, Hye Suk Lee
Aschantin, a tetrahydrofurofuran lignan with a 1,3-benzodioxole group derived from Flos Magnoliae, exhibits antioxidant, anti-inflammatory, cytotoxic, and antimicrobial activities. This study compared the metabolic profiles of aschantin in human, dog, mouse, and rat hepatocytes using liquid chromatography-high-resolution mass spectrometry. The hepatic extraction ratio of aschantin among the four species was 0.46-0.77, suggesting that it undergoes a moderate-to-extensive degree of hepatic metabolism. Hepatocyte incubation of aschantin produced 4 phase 1 metabolites, including aschantin catechol (M1), O-desmethylaschantin (M2 and M3), and hydroxyaschantin (M4), and 14 phase 2 metabolites, including O-methyl-M1 (M5 and M6) via catechol O-methyltransferase (COMT), six glucuronides of M1, M2, M3, M5, and M6, and six sulfates of M1, M2, M3, M5, and M6...
January 5, 2024: Archives of Pharmacal Research
https://read.qxmd.com/read/38176735/biocatalysis-using-thermostable-cytochrome-p450-enzymes-in-bacterial-membranes-comparison-of-metabolic-pathways-with-human-liver-microsomes-and-recombinant-human-enzymes
#9
JOURNAL ARTICLE
Ulrik Jurva, Ann-Sofie Sandinge, Jong Min Baek, Mickael Avanthay, Raine Es Thomson, Stephlina A D'Cunha, Shalini Andersson, Martin A Hayes, Elizabeth M J Gillam
Detailed structural characterization of small molecule metabolites is desirable during all stages of drug development, and often relies on the synthesis of metabolite standards. However, introducing structural changes into already complex, highly functionalized small molecules both regio- and stereo-selectively can be challenging using approaches that rely purely on synthetic organic chemistry, introducing delays and bottlenecks into the drug development pipeline. An alternative is to use enzymes such as the cytochromes P450 (P450s) that produce the metabolites in vivo, taking advantage of the inherent chirality of the enzyme's active site to achieve regio- and stereoselectivity...
January 4, 2024: Drug Metabolism and Disposition: the Biological Fate of Chemicals
https://read.qxmd.com/read/38137466/effect-of-cyp2c19-pharmacogenetic-testing-on-predicting-citalopram-and-escitalopram-tolerability-and-efficacy-a-retrospective-longitudinal-cohort-study
#10
JOURNAL ARTICLE
Mahmood Mahajna, Rami Abu Fanne, Matitiahu Berkovitch, Elias Tannous, Shlomo Vinker, Ilan Green, Ilan Matok
Background-Various antidepressant agents are metabolized by the CYP2C19 enzyme, including Citalopram and Escitalopram. Variation in CYP2C19 expression might give rise to different plasma concentrations of the active metabolites, potentially affecting both drugs' efficacy and tolerability. Aim-The aim of this study was to evaluate differences in the Escitalopram and Citalopram efficacy and tolerability between different CYP2C19 genotype-based metabolizing categories in outpatients suffering from major depressive disorder (MDD)...
December 7, 2023: Biomedicines
https://read.qxmd.com/read/38096743/stereoselective-separation-of-omeprazole-and-5-hydroxy-omeprazole-using-dried-plasma-spots-and-a-heart-cutting-2d-lc-approach-for-accurate-cyp2c19-phenotyping
#11
JOURNAL ARTICLE
Kenza Abouir, Caroline Samer, Romain Landry, Emmanuel Varesio, Youssef Daali
Omeprazole (OME) is a widely used gastric proton pump inhibitor, marketed as a racemic mixture comprising (S)- and (R)-enantiomers, with distinct pharmacokinetic profiles. OME is primarily metabolized by the cytochrome P450 enzymes 2C19 (CYP2C19) and 3A4 (CYP3A4). OME is a conventional probe for CYP2C19 phenotyping. Accurate measurement of these enantiomers and their metabolites is essential for pharmacokinetic studies. This article presents a sensitive and accurate two-dimensional liquid chromatography-mass spectrometry (LC-MS/MS) method for the simultaneous quantification of OME enantiomers and its hydroxylated metabolite (5-hydroxyomeprazole) in human plasma...
December 9, 2023: Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
https://read.qxmd.com/read/38093833/identification-of-the-imidazo-1-2-a-pyrazine-derivative-a4-as-a-potential-influenza-virus-nucleoprotein-inhibitor
#12
JOURNAL ARTICLE
Ping Li, Han Ju, Yihong Xing, Fabao Zhao, Varada Anirudhan, Ruikun Du, Qinghua Cui, Xinyong Liu, Lijun Rong, Peng Zhan
Influenza A viruses (IAVs) have gradually developed resistance to FDA-approved drugs, which increases the need to discover novel antivirals with new mechanisms of action. Here, we used a phenotypic screening strategy and discovered that the imidazo[1,2- a ]pyrazine derivative A4 demonstrates potent and broad-spectrum anti-influenza activity, especially for the oseltamivir-resistant H1N1/pdm09 strain. Indirect immunofluorescence assays revealed that A4 induces clustering of the viral nucleoprotein (NP) and prevents its nuclear accumulation...
December 8, 2023: ACS Pharmacology & Translational Science
https://read.qxmd.com/read/38093819/in-silico-studies-on-cytotoxicity-and-antitumoral-activity-of-acetogenins-from-annona-muricata-l
#13
JOURNAL ARTICLE
Houéfa Egidia Fallon Adido, Cristian Kallahan Silva Chagas, Gleison Gonçalves Ferreira, Mírian Letícia Carmo Bastos, Maria Fâni Dolabela
As life expectancy increases, the number of people affected by cancer is increasing. The available drugs still cause several adverse reactions, and it is important to look for less toxic drugs that act on resistant cancers. The present study evaluated the antitumor potential of acetogenins. Through a literature review, 44 acetogenins isolated from Annona muricata were selected and subjected to in silico studies to predict the physicochemical properties, pharmacokinetics (Preadmet and Admet lab), toxicity (Preadmet and Protox II) and molecular docking in caspase 3 (DockThor)...
2023: Frontiers in Chemistry
https://read.qxmd.com/read/38004576/oral-drug-absorption-and-drug-disposition-in-critically-ill-cardiac-patients
#14
JOURNAL ARTICLE
Lars-Olav Harnisch, Jürgen Brockmöller, Anne Hapke, Juliane Sindern, Ellen Bruns, Ruben Evertz, Karl Toischer, Bernhard C Danner, Dorothee Mielke, Veit Rohde, Tammam Abboud
(1) Background: In critically ill cardiac patients, parenteral and enteral food and drug administration routes may be used. However, it is not well known how drug absorption and metabolism are altered in this group of adult patients. Here, we analyze drug absorption and metabolism in patients after cardiogenic shock using the pharmacokinetics of therapeutically indicated esomeprazole. (2) Methods: The pharmacokinetics of esomeprazole were analyzed in a consecutive series of patients with cardiogenic shock and controls before and after elective cardiac surgery...
November 7, 2023: Pharmaceutics
https://read.qxmd.com/read/37808344/-cyp2c19-genotype-prevalence-and-association-with-recurrent-myocardial-infarction-in-british-south-asians-treated-with%C3%A2-clopidogrel
#15
JOURNAL ARTICLE
Emma F Magavern, Benjamin Jacobs, Helen Warren, Gherardo Finocchiaro, Sarah Finer, David A van Heel, Damian Smedley, Mark J Caulfield
BACKGROUND: Cytochrome P450 family 2 subfamily C member 19 (CYP2C19) is a hepatic enzyme involved in the metabolism of clopidogrel from a prodrug to its active metabolite. Prior studies of genetic polymorphisms in CYP2C19 and their relationship with clinical efficacy have not included South Asian populations. OBJECTIVES: The objective of this study was to assess prevalence of common CYP2C19 genotype polymorphisms in a British-South Asian population and correlate these with recurrent myocardial infarction risk in participants prescribed clopidogrel...
September 2023: JACC Adv
https://read.qxmd.com/read/37768317/drug-interaction-potential-of-high-dose-rifampicin-in-patients-with-pulmonary-tuberculosis
#16
JOURNAL ARTICLE
Ralf Stemkens, Veronique de Jager, Rodney Dawson, Andreas H Diacon, Kim Narunsky, Sherman D Padayachee, Martin J Boeree, Stijn W van Beek, Angela Colbers, Marieke J H Coenen, Elin M Svensson, Uwe Fuhr, Patrick P J Phillips, Lindsey H M Te Brake, Rob E Aarnoutse
Accumulating evidence supports the use of higher doses of rifampicin for tuberculosis (TB) treatment. Rifampicin is a potent inducer of metabolic enzymes and drug transporters, resulting in clinically relevant drug interactions. To assess the drug interaction potential of higher doses of rifampicin, we compared the effect of high-dose rifampicin (40 mg/kg daily, RIF40) and standard-dose rifampicin (10 mg/kg daily, RIF10) on the activities of major cytochrome P450 (CYP) enzymes and P-glycoprotein (P-gp). In this open-label, single-arm, two-period, fixed-order phenotyping cocktail study, adult participants with pulmonary TB received RIF10 (days 1-15), followed by RIF40 (days 16-30)...
September 28, 2023: Antimicrobial Agents and Chemotherapy
https://read.qxmd.com/read/37763122/pharmacogenetics-of-long-term-outcomes-of-schizophrenia-spectrum-disorders-the-functional-role-of-cyp2d6-and-cyp2c19
#17
JOURNAL ARTICLE
Amrit K Sandhu, Elnaz Naderi, Morenika J Wijninga, Edith J Liemburg, Group Investigators, Danielle Cath, Richard Bruggeman, Behrooz Z Alizadeh
Schizophrenia spectrum disorders (SSD) are complex mental disorders, and while treatment with antipsychotics is important, many patients do not respond or develop serious side effects. Genetic variation has been shown to play a considerable role in determining an individual's response to antipsychotic medication. However, previous pharmacogenetic (PGx) studies have been limited by small sample sizes, lack of consensus regarding relevant genetic variants, and cross-sectional designs. The current study aimed to investigate the association between PGx variants and long-term clinical outcomes in 691 patients of European ancestry with SSD...
September 4, 2023: Journal of Personalized Medicine
https://read.qxmd.com/read/37751627/production-of-an-o-desmethylated-product-a-major-human-metabolite-of-rabeprazole-sulfide-by-bacterial-p450-enzymes
#18
JOURNAL ARTICLE
Ngoc Tan Cao, Gun Su Cha, Jeong-Hoon Kim, Yujin Lee, Chul-Ho Yun, Ngoc Anh Nguyen
Rabeprazole is a common type of proton pump inhibitor (PPI) used to treat various peptic disorders. Unlike most PPI drugs, rabeprazole is spontaneously reduced to rabeprazole sulfide (thioether) when it is given to patients. As a result, rabeprazole sulfide is considered one of the active metabolites of rabeprazole. Rabeprazole sulfide is mainly metabolized to desmethyl rabeprazole sulfide by CYP2C19 and CYP2D6 in people. However, the pharmacological efficacy and safety of desmethyl rabeprazole sulfide have not yet been investigated...
September 20, 2023: Enzyme and Microbial Technology
https://read.qxmd.com/read/37742859/effects-of-short-chain-per-and-polyfluoroalkyl-substances-pfas-on-toxicologically-relevant-gene-expression-profiles-in-a-liver-on-a-chip-model
#19
JOURNAL ARTICLE
Megan E Solan, Bennett Schackmuth, Erica D Bruce, Sahar Pradhan, Christie M Sayes, Ramon Lavado
Short-chain per- and polyfluoroalkyl substances (PFAS) are highly stable and widely used environmental contaminants that pose potential health risks to humans. Aggregating reliable mechanistic information for safety assessments necessitates physiologically relevant high-throughput screening approaches. Here, we demonstrated the utility of a liver-on-a-chip model to investigate the effects of five short-chain PFAS at low (1 nM) and high (1 μM) concentrations on toxicologically-relevant gene expression profiles using the QuantiGene® Plex Assay...
September 22, 2023: Environmental Pollution
https://read.qxmd.com/read/37630204/the-effect-of-plastic-related-compounds-on-transcriptome-wide-gene-expression-on-cyp2c19-overexpressing-hepg2-cells
#20
JOURNAL ARTICLE
Matteo Rosellini, Alicia Schulze, Ejlal A Omer, Nadeen T Ali, Federico Marini, Jan-Heiner Küpper, Thomas Efferth
In recent years, plastic and especially microplastic in the oceans have caused huge problems to marine flora and fauna. Recently, such particles have also been detected in blood, breast milk, and placenta, underlining their ability to enter the human body, presumably via the food chain and other yet-unknown mechanisms. In addition, plastic contains plasticizers, antioxidants, or lubricants, whose impact on human health is also under investigation. At the cellular level, the most important enzymes involved in the metabolism of xenobiotic compounds are the cytochrome P450 monooxygenases (CYPs)...
August 8, 2023: Molecules: a Journal of Synthetic Chemistry and Natural Product Chemistry
keyword
keyword
69526
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.